Table 3.
Correlation of cerebrospinal fluid (CSF) and plasma soluble triggering receptor expressed on myeloid cells 2 (sTREM2) with Alzheimer’s disease (AD) biomarkers in patients with AD continuum (amyloid-positive group) (N=47).
CSF sTREM2 | Plasma sTREM2 | ||||
---|---|---|---|---|---|
R | P-value | R | P-value | ||
CSF | Aβ42 | – 0.152 | 0.281 | 0.128 | 0.365 |
P-tau S199 | 0.254 | 0.069 | -0.288 | 0.038 | |
T-tau | 0.455 | < 0.001 | -0.227 | 0.110 | |
Aβ42/P-tau S199 | – 0.331 | 0.017 | 0.316 | 0.022 | |
NfL | 0.018 | 0.901 | 0.457 | <0.001 | |
Plasma | NfL | 0.323 | 0.021 | 0.349 | 0.012 |
NRGN | 0.080 | 0.584 | 0.126 | 0.389 | |
Telomere | – 0.072 | 0.610 | – 0.146 | 0.303 | |
Age | 0.080 | 0.574 | 0.345 | 0.012 |
Linear regression analyses were used to demonstrate a correlation between biomarkers.
NfL neurofilament light chain, NRGN neurogranin.